Identification of demographics and comorbidities associated with Vascular Hamartomas [PDF]
Title from PDF of title page, viewed on June 2, 2016Thesis advisor: Mark HoffmanVitaIncludes bibliographical references (pages 27-32)Thesis (M.S.)--School of Medicine.
Conn, Michel
core
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma. [PDF]
Hu J, Pan L, Kong H, Lou J.
europepmc +1 more source
The emerging role of non-coding RNAs in the pathogenesis of infantile hemangioma. [PDF]
Saki N +3 more
europepmc +1 more source
The changing face of hepatic resection [PDF]
Iwatsuki, S, Sheahan, DG, Starzl, TE
core +1 more source
Bridging the Gap: Infantile Hemangioma Care Variability Among Pediatric Care Physicians in Greece. [PDF]
Alexopoulos A +9 more
europepmc +1 more source
Machine learning identifies immune-perinatal predictors of infantile hemangioma. [PDF]
Wu D, Wan N.
europepmc +1 more source
Completely ulcerated infantile hemangioma: a diagnostic challenge. [PDF]
Marquart E +7 more
europepmc +1 more source
Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review. [PDF]
Chamoun G +6 more
europepmc +1 more source
Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations. [PDF]
Chen F +10 more
europepmc +1 more source
Factors influencing treatment duration of oral propranolol in infantile hemangioma: a five-year retrospective analysis. [PDF]
Li Q +8 more
europepmc +1 more source

